Entecavir Plus Adefovir in Lamivudine-Resistant Patients

NCT00986778 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business Objectives Changed

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Lamivudine
DRUG: Entecavir
DRUG: Adefovir

Sponsor

Bristol-Myers Squibb